Laboratories are faced with increasing work pressure despite growing automation adoption.

While automation is gaining adoption – and will continue to grow over the next decade – laboratories are faced with a shortage of skilled workers to fill the currently available jobs. A key reason to this staff shortage is the dramatic ageing of the population that will be responsible for a decrease in Europe’s working-age population by about 4% by 2030.1 By 2030 – as increasing automation will be amplifying the shift towards more knowledge-intensive sectors – it is estimated that activities that require technological skills will grow in all industries across Europe, creating even more demand for workers with science and technology skills, who are already in short supply.1

At the same time, more and more laboratory jobs may be created in the next decade. Indeed, projections show that job numbers in the sector of professional, scientific, and technical services could be increased by almost 20% by 2030, which is set to be the strongest sector in terms of potential job growth in Europe.1 So, although automation is replacing more and more tasks, automation alone is not necessarily capable of compensating the staff shortage that Europe is facing for the decade to come.1

 

 

The demographic changes and shrinking workforce impact the organisation of laboratories that are now looking for new ways of reducing the pressure on staff while responding to the high testing demand.

 

Choosing versatile instrumentation with integrated automation can help address the challenges of cervical cancer screening labs.

HPV testing automation adapted to your needs
BD COR™ System

Is your cervical cancer screening laboratory ready to tackle the challenges of the future?
 

HPV test and instruments

  • Has your HPV assay been validated in a clinical trial?
  • Is your HPV assay clinically-validated for use with at-home self-collected samples?
  • Has your HPV testing instrument proved performant?

Technology integration

  • Does your lab automate HPV testing?
  • Are the preanalytical steps automated?
  • Can your assay identify HPV genotypes?
  • Can your lab run a cytology triage test on the same sample?

Multiple sample types

  • Does your assay use a harmonised workflow regardless of the specimen type?
  • Can your lab process liquid-based cytology specimens and self-collected vaginal specimens?

The triage challenge

  • Does your lab offer best-in-class triage testing such as extended genotyping and liquid-based cytology?

BD offers comprehensive HPV screening solutions that can adapt to any
lab’s size and specific needs.

 

 

1. McKinsey Global Institute. The future of work in Europe: Automation, workforce transitions, and the shifting geography of employment. June 2020.